在欧洲，使用依列卡福/替扎卡福/依伐卡福进行囊性纤维化跨膜传导调节因子治疗可减少典型囊性纤维化病原体的检出：虽已取得进展，但仍不能放慢脚步。
Cystic fibrosis transmembrane conductance regulator therapy with elexacaftor/tezacaftor/ivacaftor reduces detection of hallmark cystic fibrosis pathogens in Europe: progress made but no time to slow down.
作者信息
Schütz Katharina, Pallenberg Sophia T, Rosenboom Ilona, Dittrich Anna-Maria
机构信息
Hannover Medical School, Department for Pediatric Pneumology, Allergology and Neonatology, Hannover, Germany.
German Center for Lung Research, Biomedical Research in Endstage and Obstructive Lung Disease (BREATH), Hannover, Germany.
出版信息
ERJ Open Res. 2025 Aug 4;11(4). doi: 10.1183/23120541.00211-2025. eCollection 2025 Jul.
Zotero 插件